Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema

Scientists investigated whether lymphedema could be attenuated by interfering with urokinase plasminogen activator receptor-associated protein (uPARAP), an endocytic receptor involved in fibrosis and lymphangiogenesis.